Red, green, and blue model assessment and AQbD approach to HPTLC method for concomitant analysis of metformin, pioglitazone, and teneligliptin
Abstract Background The CDSCO of India has authorized a combination of metformin hydrochloride, teneligliptin hydrochloride, and pioglitazone hydrochloride for the treatment of insulin-independent diabetes. For the purpose of estimating metformin, teneligliptin, and pioglitazone combinations as well...
Kaydedildi:
| Asıl Yazarlar: | , , , , |
|---|---|
| Materyal Türü: | Artigo |
| Dil: | Inglês |
| Baskı/Yayın Bilgisi: |
SpringerOpen
2024-11-01
|
| Seri Bilgileri: | Future Journal of Pharmaceutical Sciences |
| Konular: | |
| Online Erişim: | https://doi.org/10.1186/s43094-024-00746-7 |
| Etiketler: |
Etiket eklenmemiş, İlk siz ekleyin!
|